Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019.
van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M; InCHEHC study group.
van Santen DK, et al. Among authors: wittkop l.
EClinicalMedicine. 2022 Dec 30;56:101810. doi: 10.1016/j.eclinm.2022.101810. eCollection 2023 Feb.
EClinicalMedicine. 2022.
PMID: 36618902
Free PMC article.